PAMAM-calix-dendrimers as carriers for 5-fluorouracil: complexation, aggregation, and in vitro antitumor activity
Open Access
- 10 December 2025
- journal article
- Published by Ural Federal University in Chimica Techno Acta
- Vol. 13 (1) , 9369
Abstract
Despite a number of serious challenges and limitations in clinical use, drug therapy is considered one of the most common approaches to treating cancer. However, many types of cancer become resistant to antitumor drugs. Modern supramolecular chemistry provides a variety of compounds and materials that can be used to develop targeted drug delivery approaches, thereby enhancing therapeutic efficacy. Dendrimers are one example of such materials. This study presents an approach to creating supramolecular systems based on poly(amidoamine) dendrimers with a thiacalix[4]arene core (PAMAM-calix-dendrimers), capable of binding and delivering 5-fluorouracil (5-Fu). Fluorescence spectroscopy has demonstrated the good binding of 5-Fu by G1–G3 PAMAM-calix-dendrimers (logKa = 3.15–3.62) regardless of the macrocyclic core conformation. Self-assembly of the PAMAM-calix-dendrimers/5-Fu supramolecular systems was studied by dynamic light scattering and transmission electron microscopy. Loading and release of 5-Fu were evaluated by UV-Vis spectroscopy. The encapsulation efficiency and loading capacity increased slightly in the following order: G3-cone G3-paco G3-alt. For all dendrimers studied, 95% release of 5-Fu was observed within 4 h. An in vitro HeLa tumor cell model showed a positive trend (up to 20%) toward overcoming resistance to 5-Fu chemotherapy when G3-alt is used. These results provide proof of concept for using macrocyclic dendrimers to create anticancer drug delivery systems.Keywords
This publication has 43 references indexed in Scilit:
- Combination of Dendrimers and Exosomes: Implications for Biomedical ApplicationsMacromolecular Bioscience, 2025
- Design of reversible cholinesterase inhibitors: Fine-tuning of enzymatic activity by PAMAM-calix-dendrimersInternational Journal of Biological Macromolecules, 2024
- Multifunctional PAMAM Dendrimers Carrying SAHA, 5‐FU, and a Therapeutic Gene for Targeted Co‐Delivery Toward Colorectal Cancer CellsBiotechnology Journal, 2024
- Resistance to 5-fluorouracil: The molecular mechanisms of development in colon cancer cellsEuropean Journal of Pharmacology, 2024
- Challenges and Future Directions of Anticancer Molecules and Their Delivery2024
- Dendrimer‐Based Nanodrugs for Chemodynamic Therapy of TumorsAdvanced NanoBiomed Research, 2024
- The relationship between tumor metabolism and 5-fluorouracil resistanceBiochemical Pharmacology, 2023
- 5-Fluorouracil nano-delivery systems as a cutting-edge for cancer therapyEuropean Journal of Medicinal Chemistry, 2022
- Emerging innate biological properties of nano-drug delivery systems: A focus on PAMAM dendrimers and their clinical potentialAdvanced Drug Delivery Reviews, 2021
- Targeted anticancer therapy: Overexpressed receptors and nanotechnologyClinica Chimica Acta, 2014